Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Hidekazu Shirota & Dennis M Klinman. (2014) Recent progress concerning CpG DNA and its use as a vaccine adjuvant. Expert Review of Vaccines 13:2, pages 299-312.
Read now
Read now
Takeshi Arakawa. (2011) Adjuvants: no longer a ‘dirty little secret’, but essential key players in vaccines of the future. Expert Review of Vaccines 10:1, pages 1-5.
Read now
Read now
Ali M Harandi, Gwyn Davies & Ole F Olesen. (2009) Vaccine adjuvants: scientific challenges and strategic initiatives. Expert Review of Vaccines 8:3, pages 293-298.
Read now
Read now
Mansour Mohamadzadeh, Tri Duong, Timothy Hoover & Todd R Klaenhammer. (2008) Targeting mucosal dendritic cells with microbial antigens from probiotic lactic acid bacteria. Expert Review of Vaccines 7:2, pages 163-174.
Read now
Read now
Articles from other publishers (47)
Jacques C. Mbongue, Elaine Vanterpool, Anthony Firek & William H. R. Langridge. (2022) Lipopolysaccharide-Induced Immunological Tolerance in Monocyte-Derived Dendritic Cells. Immuno 2:3, pages 482-500.
Crossref
Crossref
Yixin Shi, Chao Pan, Kangfeng Wang, Yan Liu, Yange Sun, Yan Guo, Peng Sun, Jun Wu, Ying Lu, Li Zhu & Hengliang Wang. (2022) Construction of Orthogonal Modular Proteinaceous Nanovaccine Delivery Vectors Based on mSA-Biotin Binding. Nanomaterials 12:5, pages 734.
Crossref
Crossref
Hussain A. Alabdullah, Elise Overgaard, Danielle Scarbrough, Janet E. Williams, Omid Mohammad Mousa, Gary Dunn, Laura Bond, Mark A. McGuire & Juliette K. Tinker. (2020) Evaluation of the Efficacy of a Cholera Toxin-Based Staphylococcus aureus Vaccine against Bovine Intramammary Challenge. Vaccines 9:1, pages 6.
Crossref
Crossref
Jing Zhao, Jinqi Li, Zhongliang Jiang, Rongsheng Tong, Xingmei Duan, Lan Bai & Jianyou Shi. (2020) Chitosan, N,N,N-trimethyl chitosan (TMC) and 2-hydroxypropyltrimethyl ammonium chloride chitosan (HTCC): The potential immune adjuvants and nano carriers. International Journal of Biological Macromolecules 154, pages 339-348.
Crossref
Crossref
Mohammad Ariful Islam, Jannatul Firdous, Abu Zayed Md Badruddoza, Emma Reesor, Mohammad Azad, Anwarul Hasan, Michael Lim, Wuji Cao, Simon Guillemette & Chong Su Cho. (2019) M cell targeting engineered biomaterials for effective vaccination. Biomaterials 192, pages 75-94.
Crossref
Crossref
Hidehiko Suzuki, Koji Hosomi, Ayaka Nasu, Masuo Kondoh & Jun Kunisawa. (2018) Development of Adjuvant-Free Bivalent Food Poisoning Vaccine by Augmenting the Antigenicity of Clostridium perfringens Enterotoxin. Frontiers in Immunology 9.
Crossref
Crossref
Rui Tada, Daisuke Yamanaka, Miki Ogasawara, Momoko Saito, Naohito Ohno, Hiroshi Kiyono, Jun Kunisawa & Yukihiko Aramaki. (2018) Polymeric Caffeic Acid Is a Safer Mucosal Adjuvant That Augments Antigen-Specific Mucosal and Systemic Immune Responses in Mice. Molecular Pharmaceutics 15:9, pages 4226-4234.
Crossref
Crossref
Rui Tada, Shoko Muto, Tomoko Iwata, Akira Hidaka, Hiroshi Kiyono, Jun Kunisawa & Yukihiko Aramaki. (2017) Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice. BMC Research Notes 10:1.
Crossref
Crossref
Xianliang Ji, Zhiguang Ren, Na Xu, Lingnan Meng, Zhijun Yu, Na Feng, Xiaoyu Sang, Shengnan Li, Yuanguo Li, Tiecheng Wang, Yongkun Zhao, Hualei Wang, Xuexing Zheng, Hongli Jin, Nan Li, Songtao Yang, Jinshan Cao, Wensen Liu, Yuwei Gao & Xianzhu Xia. (2016) Intranasal Immunization with Influenza Virus-Like Particles Containing Membrane-Anchored Cholera Toxin B or Ricin Toxin B Enhances Adaptive Immune Responses and Protection against an Antigenically Distinct Virus. Viruses 8:4, pages 115.
Crossref
Crossref
Rui Tada, Akira Hidaka, Naoko Iwase, Saeko Takahashi, Yuki Yamakita, Tomoko Iwata, Shoko Muto, Emi Sato, Noriko Takayama, Emi Honjo, Hiroshi Kiyono, Jun Kunisawa & Yukihiko Aramaki. (2015) Intranasal Immunization with DOTAP Cationic Liposomes Combined with DC-Cholesterol Induces Potent Antigen-Specific Mucosal and Systemic Immune Responses in Mice. PLOS ONE 10:10, pages e0139785.
Crossref
Crossref
Jinyoung Lee, Jong-Kyun Yoo, Hae-Jin Sohn, Hee-kyoung Kang, Daesik Kim, Ho-Joon Shin & Jong-Hyun Kim. (2015) Protective immunity against Naegleria fowleri infection on mice immunized with the rNfa1 protein using mucosal adjuvants. Parasitology Research 114:4, pages 1377-1385.
Crossref
Crossref
Jitinder S. Wilkhu & Yvonne Perrie. 2015. Subunit Vaccine Delivery. Subunit Vaccine Delivery
95
123
.
Shashwati U. Atwe, Yunzhe Ma & Harvinder Singh Gill. (2014) Pollen grains for oral vaccination. Journal of Controlled Release 194, pages 45-52.
Crossref
Crossref
Chunfeng Guan, Jing Ji, Chao Jin, Gang Wang, Xiaozhou Li & Wenzhu Guan. (2014) Expression of cholera toxin B subunit-lumbrokinase in edible sunflower seeds-the use of transmucosal carrier to enhance its fusion protein's effect on protection of rats and mice against thrombosis. Biotechnology Progress 30:5, pages 1029-1039.
Crossref
Crossref
Guan Chunfeng, Li Xiaozhou, Wang Gang, Ji Jing, Jin Chao & Tchouopou Lontchi Josine. (2012) Expression of Cholera Toxin B–Lumbrokinase Fusion Protein in Pichia pastoris—The Use of Transmucosal Carriers in the Delivery of Therapeutic Proteins to Protect Rats Against Thrombosis. Applied Biochemistry and Biotechnology 169:2, pages 636-650.
Crossref
Crossref
Ana Vujanic, Philip Sutton, Kenneth J. Snibson, Hung-Hsun Yen & Jean-Pierre Y. Scheerlinck. (2012) Mucosal vaccination: Lung versus nose. Veterinary Immunology and Immunopathology 148:1-2, pages 172-177.
Crossref
Crossref
Sheena H. Wang, Shaun M. Kirwan, Soman N. Abraham, Herman F. Staats & Anthony J. Hickey. (2012) Stable Dry Powder Formulation for Nasal Delivery of Anthrax Vaccine. Journal of Pharmaceutical Sciences 101:1, pages 31-47.
Crossref
Crossref
Adam K.A. Wright, Ioanna Christopoulou, Sherouk El Batrawy, Jane Limer & Stephen B. Gordon. (2011) rhIL-12 as adjuvant augments lung cell cytokine responses to pneumococcal whole cell antigen. Immunobiology 216:10, pages 1143-1147.
Crossref
Crossref
Jitinder Wilkhu, Sarah E McNeil, Daniel J Kirby & Yvonne Perrie. (2011) Formulation design considerations for oral vaccines. Therapeutic Delivery 2:9, pages 1141-1164.
Crossref
Crossref
MR Popoff. (2011) Multifaceted interactions of bacterial toxins with the gastrointestinal mucosa. Future Microbiology 6:7, pages 763-797.
Crossref
Crossref
Lissette S. Velasquez, Samantha Shira, Alice N. Berta, Jacquelyn Kilbourne, Babu M. Medi, Ian Tizard, Yawei Ni, Charles J. Arntzen & Melissa M. Herbst-Kralovetz. (2011) Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine. Vaccine 29:32, pages 5221-5231.
Crossref
Crossref
Nguyen-Xuan Huy, Moon-Sik Yang & Tae-Geum Kim. (2010) Expression of a Cholera Toxin B Subunit-Neutralizing Epitope of the Porcine Epidemic Diarrhea Virus Fusion Gene in Transgenic Lettuce (Lactuca sativa L.). Molecular Biotechnology 48:3, pages 201-209.
Crossref
Crossref
Anja Krause, Wen Zhu Whu, Yaqin Xu, Ju Joh, Ronald G. Crystal & Stefan Worgall. (2011) Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF. Vaccine 29:11, pages 2131-2139.
Crossref
Crossref
Melanie Cochrane, Charles W Armitage, Connor P O’Meara & Kenneth W Beagley. (2010)
Towards a
Chlamydia trachomatis
vaccine: how close are we?
. Future Microbiology 5:12, pages 1833-1856.
Crossref
Crossref
Lissette S. Velasquez, Brooke E. Hjelm, Charles J. Arntzen & Melissa M. Herbst-Kralovetz. (2010) An Intranasally Delivered Toll-Like Receptor 7 Agonist Elicits Robust Systemic and Mucosal Responses to Norwalk Virus-Like Particles. Clinical and Vaccine Immunology 17:12, pages 1850-1858.
Crossref
Crossref
Ali M. Harandi, Donata Medaglini & Robin J. Shattock. (2010) Vaccine adjuvants: A priority for vaccine research. Vaccine 28:12, pages 2363-2366.
Crossref
Crossref
Luis G. Bermúdez-Humarán & Philippe Langella. (2009) Utilisation des bactéries lactiques comme vecteurs vaccinaux. Revue Francophone des Laboratoires 2009:417, pages 79-89.
Crossref
Crossref
Edmund J. Gosselin, Constantine Bitsaktsis, Ying Li & Bibiana V. Iglesias. (2009) Fc receptor-targeted mucosal vaccination as a novel strategy for the generation of enhanced immunity against mucosal and non-mucosal pathogens. Archivum Immunologiae et Therapiae Experimentalis 57:5, pages 311-323.
Crossref
Crossref
Caleb G. Chen, Yen-Ta Lu, Marie Lin, Natalia Savelyeva, Freda K. Stevenson & Delin Zhu. (2009) Amplification of immune responses against a DNA-delivered idiotypic lymphoma antigen by fusion to the B subunit of E. coli heat labile toxin. Vaccine 27:32, pages 4289-4296.
Crossref
Crossref
Annemarie Hasselberg, Karin Schön, Andrej Tarkowski & Nils Lycke. (2009) Role of CTA1R7K-COL-DD as a novel therapeutic mucosal tolerance-inducing vector for treatment of collagen-induced arthritis. Arthritis & Rheumatism 60:6, pages 1672-1682.
Crossref
Crossref
Constantine Bitsaktsis, Deepak B. Rawool, Ying Li, Nitin V. Kurkure, Bibiana Iglesias & Edmund J. Gosselin. (2009)
Differential Requirements for Protection against Mucosal Challenge with
Francisella tularensis
in the Presence versus Absence of Cholera Toxin B and Inactivated
F. tularensis
. The Journal of Immunology 182:8, pages 4899-4909.
Crossref
Crossref
Tae-Bin Won, Song-Hua Quan, Dong-Young Kim, Chae-Seo Rhee & Chul Hee Lee. (2009) Immunostimulatory sequence oligdeoxynucleotide/cholera toxin B conjugate: a novel allergen-independent intranasal vaccine for allergic rhinitis. Annals of Allergy, Asthma & Immunology 102:4, pages 314-322.
Crossref
Crossref
C.-F. Huang, T.-C. Wu, Y.-H. Chu, K.-S. Hwang, C.-C. Wang & H.-J. Peng. (2008) Effect of Neonatal Sublingual Vaccination with Native or Denatured Ovalbumin and Adjuvant CpG or Cholera Toxin on Systemic and Mucosal Immunity in Mice. Scandinavian Journal of Immunology 68:5, pages 502-510.
Crossref
Crossref
Sara Tengvall, Derek O’Hagan & Ali M. Harandi. (2008) Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: Relative importance of myeloid differentiation factor 88. Antiviral Research 78:3, pages 202-214.
Crossref
Crossref
J. Nyström-Asklin, J. Adamsson & A. M. Harandi. (2008) The Adjuvant Effect of CpG Oligodeoxynucleotide Linked to the Non-Toxic B Subunit of Cholera Toxin for Induction of Immunity Against H. pylori in Mice. Scandinavian Journal of Immunology 67:5, pages 431-440.
Crossref
Crossref
Ching-Feng Huang, Chih-Chien Wang, Tzee-Chung Wu, Keh-Gong Wu, Chin-Cheng Lee & Ho-Jen Peng. (2008) Neonatal Sublingual Vaccination with Salmonella Proteins and Adjuvant Cholera Toxin or CpG Oligodeoxynucleotides Induces Mucosal and Systemic Immunity in Mice. Journal of Pediatric Gastroenterology & Nutrition 46:3, pages 262-271.
Crossref
Crossref
Ching-Feng Huang, Chih-Chien Wang, Tzee-Chung Wu, Chia-Hsiang Chu & Ho-Jen Peng. (2007) Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG oligodeoxynucleotides or cholera toxin on systemic TH2 immune responses and mucosal immunity in mice. Annals of Allergy, Asthma & Immunology 99:5, pages 443-452.
Crossref
Crossref
J.-B. Sun, N. Cuburu, M. Blomquist, B.-L. Li, C. Czerkinsky & J. Holmgren. (2006) Sublingual Tolerance Induction with Antigen Conjugated to Cholera Toxin B Subunit Induces Foxp3+CD25+CD4+ Regulatory T Cells and Suppresses Delayed-Type Hypersensitivity Reactions. Scandinavian Journal of Immunology 64:3, pages 251-259.
Crossref
Crossref
Jenni Adamsson, Marianne Lindblad, Annika Lundqvist, Denise Kelly, Jan Holmgren & Ali M. Harandi. (2006) Novel Immunostimulatory Agent Based on CpG Oligodeoxynucleotide Linked to the Nontoxic B Subunit of Cholera Toxin. The Journal of Immunology 176:8, pages 4902-4913.
Crossref
Crossref
Michael J. McCluskie & Risini D. Weeratna. 2006. Immunopotentiators in Modern Vaccines. Immunopotentiators in Modern Vaccines
73
92
.
Marcel Maier, Timothy J. Seabrook & Cynthia A. Lemere. (2005) Modulation of the humoral and cellular immune response in Aβ immunotherapy by the adjuvants monophosphoryl lipid A (MPL), cholera toxin B subunit (CTB) and E. coli enterotoxin LT(R192G). Vaccine 23:44, pages 5149-5159.
Crossref
Crossref
Bernd H. Zinselmeyer, John Dempster, Alison M. Gurney, David Wokosin, Mark Miller, Hsiang Ho, Owain R. Millington, Karen M. Smith, Catherine M. Rush, Ian Parker, Michael Cahalan, James M. Brewer & Paul Garside. (2005) In situ characterization of CD4+ T cell behavior in mucosal and systemic lymphoid tissues during the induction of oral priming and tolerance. The Journal of Experimental Medicine 201:11, pages 1815-1823.
Crossref
Crossref
Jan Holmgren & Cecil Czerkinsky. (2005) Mucosal immunity and vaccines. Nature Medicine 11:S4, pages S45-S53.
Crossref
Crossref
Nils Lycke. (2005) From toxin to adjuvant: basic mechanisms for the control of mucosal IgA immunity and tolerance. Immunology Letters 97:2, pages 193-198.
Crossref
Crossref
Jan Holmgren, Jenni Adamsson, Fabienne Anjuère, John Clemens, Cecil Czerkinsky, Kristina Eriksson, Carl-Fredrik Flach, Annie George-Chandy, Ali M. Harandi, Michael Lebens, Thomas Lehner, Marianne Lindblad, Erik Nygren, Sukanya Raghavan, Joaquin Sanchez, Michael Stanford, Jia-Bin Sun, Ann-Mari Svennerholm & Sara Tengvall. (2005) Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. Immunology Letters 97:2, pages 181-188.
Crossref
Crossref
Fabrice Cognasse, Sophie Acquart, Lydie Beniguel, Odile Sabido, Patricia Chavarin, Christian Genin & Olivier Garraud. (2005) Differential production of immunoglobulin classes and subclasses by mucosal-type human B-lymphocytes exposed in vitro to CpG oligodeoxynucleotides. Clinical Chemistry and Laboratory Medicine (CCLM) 43:1.
Crossref
Crossref
Jan NilssonGöran K. HanssonPrediman K. Shah. (2005) Immunomodulation of Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 25:1, pages 18-28.
Crossref
Crossref